Long-term Outcomes, Recurrence Rates, and Treatment Needs in Polypoidal Choroidal Vasculopathy (PCV)
Launched by SINGAPORE NATIONAL EYE CENTRE · Apr 26, 2019
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the long-term outcomes of a condition called Polypoidal Choroidal Vasculopathy (PCV). Researchers want to find out how often PCV comes back after treatment, what kind of treatments patients need, and whether closing the abnormal blood vessels in the eye within the first year leads to better vision in the long run. They will also look into how likely it is for the other eye to develop this condition.
To participate in this study, individuals must have previously taken part in certain PCV clinical trials and be able to provide consent for this follow-up. There are no strict exclusion criteria, so as long as someone meets the inclusion requirements, they can join. Participants can expect to share their experiences and outcomes regarding their PCV treatment over the past five years, helping doctors better understand this condition and improve future care for others.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants will have completed the previous PCV RCTs: EVEREST II, PLANET and PCV T\&E studies
- • Are able to give consent for this follow up study
- Exclusion Criteria:
- • No exclusion criteria unless they do not meet the inclusion criteria
About Singapore National Eye Centre
The Singapore National Eye Centre (SNEC) is a premier institution dedicated to advancing ophthalmic care through innovative research and clinical excellence. As a leading clinical trial sponsor, SNEC focuses on improving the diagnosis and treatment of a wide range of eye conditions, leveraging cutting-edge technologies and methodologies. Committed to enhancing patient outcomes, SNEC collaborates with a network of healthcare professionals and researchers to conduct rigorous clinical trials that contribute to the global understanding of ocular health. Their comprehensive approach integrates patient care with scientific inquiry, ensuring that advancements in eye care are both evidence-based and aligned with the needs of the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Singapore, , Singapore
Singapore, , Singapore
Patients applied
Trial Officials
Principal Investigator
Principal Investigator
Singapore National Eye Centre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials